Martingale Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65M | Sell |
5,445
-99
| -2% | -$30K | 0.04% | 341 |
|
|
2025
Q1 | $1.84M | Sell |
5,544
-370
| -6% | -$123K | 0.05% | 317 |
|
|
2024
Q4 | $1.82M | Buy |
5,914
+150
| +3% | +$46.3K | 0.04% | 332 |
|
|
2024
Q3 | $1.22M | Buy |
+5,764
| New | +$1.22M | 0.03% | 416 |
|
|
2024
Q2 | – | Sell |
-6,163
| Closed | -$1.65M | – | 826 |
|
|
2024
Q1 | $1.65M | Sell |
6,163
-481
| -7% | -$128K | 0.03% | 346 |
|
|
2023
Q4 | $1.54M | Buy |
6,644
+661
| +11% | +$153K | 0.03% | 348 |
|
|
2023
Q3 | $874K | Buy |
5,983
+1,751
| +41% | +$256K | 0.02% | 474 |
|
|
2023
Q2 | $978K | Buy |
4,232
+100
| +2% | +$23.1K | 0.02% | 454 |
|
|
2023
Q1 | $1M | Buy |
+4,132
| New | +$1M | 0.02% | 442 |
|
|
2021
Q4 | – | Sell |
-5,404
| Closed | -$432K | – | 862 |
|
|
2021
Q3 | $432K | Buy |
5,404
+2,801
| +108% | +$224K | 0.01% | 693 |
|
|
2021
Q2 | $254K | Buy |
+2,603
| New | +$254K | ﹤0.01% | 752 |
|